STRS Ohio’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-8,700
Closed -$215K 2043
2022
Q1
$215K Hold
8,700
﹤0.01% 1686
2021
Q4
$302K Buy
+8,700
New +$276K ﹤0.01% 1615
2017
Q3
Sell
-1,500
Closed -$35K 1916
2017
Q2
$35K Hold
1,500
﹤0.01% 1841
2017
Q1
$41K Buy
+1,500
New +$34.9K ﹤0.01% 1791

Other funds holding ANAB

STRS Ohio's ANAB Position: Q2 2022 in Review

STRS Ohio sold out of AnaptysBio (ANAB) in Q2 2022, closing a stake of 8,700 shares — an estimated $215K sold.

STRS Ohio first reported a position in ANAB in Q1 2017 and held it in 4 quarters. The position peaked at $302K in Q4 2021. 124 funds tracked by Wall St. Rank hold ANAB as of Q2 2022.

  • STRS Ohio reported no remaining AnaptysBio position as of Q2 2022 after selling out during the quarter.
  • STRS Ohio sold 8,700 AnaptysBio shares in Q2 2022, an estimated $215K.
  • STRS Ohio first reported a position in AnaptysBio in Q1 2017 and held it in 4 quarters.
  • STRS Ohio's AnaptysBio position peaked at $302K in Q4 2021.
  • 124 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.